AHL
ATYR

Abel Hall LLC’s aTyr Pharma ATYR Stock Holding History

Abel Hall LLC’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2K Buy
+22,117
New +$14.4K ﹤0.01% 949

Other funds holding ATYR

CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM
VR
Vision Retirement Ridgewood, New Jersey $414M AUM
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Abel Hall LLC's ATYR Position: Q2 2026 in Review

Abel Hall LLC opened a new position in aTyr Pharma (ATYR) in Q2 2026: 22,117 shares worth $13.2K. The stake represents ﹤0.01% of the portfolio and ranks #949 among its holdings.

16 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Abel Hall LLC held 22,117 shares of aTyr Pharma worth $13.2K as of Q2 2026.
  • aTyr Pharma was a new Abel Hall LLC position in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Abel Hall LLC's portfolio in Q2 2026, its #949 holding.
  • 16 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.